Subscribe today to receive notice of our latest thought leadership, articles, blogs and updates.
Insights
Blogs
Sharing perspectives leads to greater understanding and fuels innovation
Check out our latest blog posts:
|
October 04, 2023 · Public Policy & Regulatory Affairs Team
Brief updates include Colorado furthering limits on physician dispensing in work comp, California work comp bill requiring in-state licensure for UR physicians on hold, Arizona Fee Schedule features new DMEPOS requirements, Tennessee activates Certified Physician Program and New York PTSD bill keeps moving. Read more... |
|
September 20, 2023 · Clinical Team
Zavzpret – indicated for the acute treatment of migraine with or without aura in adults – is now available as a 10 mg nasal spray device. Read more... |
|
|
September 15, 2023 · Clinical Team
According to the U.S. Food and Drug Administration (FDA), Duexis — a single-tablet combination product containing ibuprofen, a nonsteroidal anti‐inflammatory drug (NSAID), and famotidine, a histamine H2–receptor blocker — will no longer be manufactured. Read more... |
|
|
September 13, 2023 · Public Policy & Regulatory Affairs Team
Read more... |
|
|
September 01, 2023 · Clinical Team
Earlier this year, the American Geriatrics Society (AGS) published an update to the AGS Beers Criteria® for potentially inappropriate medication (PIM) use in older adults (65 years of age and older). Older adults are more likely to experience unwanted adverse effects and be more sensitive to certain medications. Read more... |
|
August 23, 2023 · Medicare Insights Team
On August 8, the Center for Medicare & Medicaid Services (CMS) released an updated Non-Group Health Plan (NGHP) User Guide, Version 7.2, which includes important updates. Read more... |
|
|
August 16, 2023 · Public Policy & Regulatory Affairs Team
Brief postings include proposed updates to California DWC medical treatment guidelines and the Michigan Supreme Court rules on retro-applicability of certain auto no-fault fee schedule provisions. Read more... |
|
|
August 11, 2023 · Clinical Team
FDA approves additional over-the-counter naloxone products Read more... |
Page 4 of 19
